Zinc-finger-based artificial transcription factors and their applications

Advanced Drug Delivery Reviews

Volumn 61, Issue 7-8, 2009, Pages 513-526

  Sera, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antiviral therapy; Artificial transcription factor; DNA recognition; Gene regulation; Gene therapy; Transcriptional effector domain; Zinc finger proteins

Indexed keywords

ANTIVIRAL THERAPY; ARTIFICIAL TRANSCRIPTION FACTOR; DNA RECOGNITION; GENE REGULATION; GENE THERAPY; TRANSCRIPTIONAL EFFECTOR DOMAIN;

DNA; GENES; GENETIC ENGINEERING; NUCLEIC ACIDS; TRANSCRIPTION FACTORS; ZINC;

TRANSCRIPTION;

AMINO ACID; CELL PENETRATING PEPTIDE; CHECKPOINT KINASE 2; CHOLECYSTOKININ B RECEPTOR; CYSTEINE; DNA BINDING PROTEIN; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; ERYTHROPOIETIN; GAMMA GLOBIN; HISTIDINE; MASPIN; OCTAMER TRANSCRIPTION FACTOR 4; PARATHYROID HORMONE RECEPTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN; PROTEIN BAX; PROTEIN H19; SOMATOMEDIN B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UTROPHIN; VASCULOTROPIN A; ZINC FINGER PROTEIN;

ANTIVIRAL THERAPY; BINDING SITE; CELL MEMBRANE PERMEABILITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME; DNA BINDING; DNA BINDING MOTIF; DNA SEQUENCE; DNA STRUCTURE; DNA VIRUS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ERBB GENE; ERYTHROPOIETIN GENE; GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GENE THERAPY; H19 GENE; HUMAN; IGF2 GENE; IN VIVO STUDY; MASPIN GENE; MDR1 GENE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA VIRUS; UPREGULATION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; DNA; GENE EXPRESSION; GENE LIBRARY; GENE THERAPY; HUMANS; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 65749115965     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.03.012     Document Type: Review

References (114)

1. Miller J., McLachlan A.D., and Klug A. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J. 4 (1985) 1609-1614
2. Klug A., and Schwabe J.W.R. Protein motif 5: zinc fingers. FASEB J. 9 (1995) 597-604
3. Pavletich N.P., and Pabo C.O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 Ǻ. Science 252 (1991) 809-817
4. Elrod-Erickson M., Roud M.A., Nekludova L., and Pabo C.O. Zif268 protein-DNA complex refined at 1.6 Ǻ: a model system for understanding zinc finger-DNA interactions. Structure 4 (1996) 1171-1180
5. Kim C.A., and Berg J.M. A 2.2 Ǻ resolution crystal structure of a designed zinc finger protein bound to DNA. Nat. Struct. Biol. 3 (1996) 940-945
6. Krizek B.A., Amann B.T., Kilfoil V.J., Merkle D.L., and Berg J.M. A consensus zinc finger peptide: design, high-affinity metal binding, a pH-dependent structure, and a His to Cys sequence variant. J. Am. Chem. Soc. 113 (1991) 4518-4523
7. Desjarlais J.R., and Berg J.M. Use of a zinc-finger consensus sequence framework and specificity rules to design specific DNA-binding proteins. Proc. Natl. Acad. Sci. USA 90 (1993) 2256-2260
8. Desjarlais J.R., and Berg J.M. Length-encoded multiplex binding site determination: application to zinc finger proteins. Proc. Natl. Acad. Sci. USA 91 (1994) 11099-11103
9. Shi Y., and Berg J.M. A direct comparison of the properties of natural and designed zinc-finger proteins. Chem. Biol. 2 (1995) 83-89
10. 2 zinc finger peptide is not, in general, responsible for base recognition. J. Mol. Biol. 252 (1995) 1-5
11. Segal D.J., Dreier B., Beerli R.R., and Barbas III C.F. Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences. Proc. Natl. Acad. Sci. USA 96 (1999) 2758-2763
12. Maeder M.L., Thibodeau-Beganny S., Osiak A., Wright D.A., Anthony R.M., Eichtinger M., Jiang T., Foley J.E., Winfrey R.J., Townsend J.A., Unger-Wallace E., Snader J.D., Müller-Lerch F., Fu F., Pearlberg J., Göbel C., Dassie J.P., Pruett-Miller S.M., Porteus M.H., Sgroi D.C., Iafrate A.J., Dobbs D., McCray Jr. P.B., Cathomen T., Voytas D.F., and Joung J.K. Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell 31 (2008) 294-301
13. Isalan M., Choo Y., and Klug A. Synergy between adjacent zinc fingers in sequence-specific DNA recognition. Proc. Natl. Acad. Sci. USA 94 (1997) 5617-5621
14. Choo Y. End effects in DNA recognition by zinc finger arrays. Nucleic Acids Res. 26 (1998) 554-557
15. Isalan M., Klug A., and Choo Y. Comprehensive DNA recognition through concerted interactions from adjacent zinc fingers. Biochemistry 37 (1998) 12026-12033
16. Sera T., and Uranga C. Rational design of artificial zinc-finger proteins using a nondegenerate recognition code table. Biochemistry 41 (2002) 7074-7081
17. Desjarlais J.R., and Berg J.M. Toward rules relating zinc finger protein sequences and DNA-binding site preferences. Proc. Natl. Acad. Sci. USA 89 (1992) 7345-7349
18. Thukral S.K., Morrison M.L., and Young E.T. Mutations in the zinc fingers of ADR1 that change the specificity of DNA binding and transctivation. Mol. Cell. Biol. 12 (1992) 2784-2792
19. Rebar E.J., and Pabo C.O. Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science 263 (1993) 671-673
20. Jamieson A.C., Kim S.-H., and Wells J.A. In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry 33 (1994) 5689-5695
21. Choo Y., and Klug A. Toward a code for the interactions of zinc fingers with DNA: selection of randomized fingers displayed on phage. Proc. Natl. Acad. Sci. USA 92 (1995) 344-348
22. Wu H., Yang W.-P., and Barbas III C.F. Building zinc fingers by selection: toward a therapeutic application. Proc. Natl. Acad. Sci. USA 91 (1994) 11163-11167
23. Choo Y., and Isalan M. Advances in zinc finger engineering. Curr. Opin. Struct. Biol. 10 (2000) 41-416
24. Beerli R.R., and Barbas III C.F. Engineering polydactyl zinc-finger transcription factors. Nat. Biotrechnol. 20 (2002) 135-141
25. Jamieson A.C., Miller J.C., and Pabo C.O. Drug discovery with engineered zinc-finger proteins. Nat. Rev. Drug. Discov. 2 (2003) 361-368
26. Uil T.G., Haisma H.J., and Rots M.G. Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities. Nucleic Acids Res. 31 (2003) 6064-6078
27. 2 zinc finger DNA-binding domains. Gene Ther. Regul. 2 (2004) 191-206
28. Porteus M.H., and Carroll D. Gene targeting using zinc finger nucleases. Nat. Biotechnol. 23 (2005) 967-973
29. Negi S., Imanishi M., Matsumoto M., and Sugiura Y. New redesigned zinc-finger proteins: design strategy and its application. Chem. Eur. J. 14 (2008) 3236-3249
30. Liu P.-P., Rebar E.J., Zhang L., Liu Q., Jamieson A.C., Liang Y., Qi H., Li P.-X., Chen B., Mendel M.C., Zhong X., Lee Y.-L., Eisenberg S.P., Spratt S.K., Case C.C., and Wolffe A.P. Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. J. Biol. Chem. 276 (2001) 11323-11334
31. Zhang L., Spratt S.K., Liu Q., Johnstone B., Qi H., Raschke E.E., Jamieson A.C., Rebar E.J., Wolffe A.P., and Case C.C. Synthetic zinc finger transcription factor action at an endogenous chromosomal site. J. Biol. Chem. 275 (2000) 33850-33860
32. Jouvenot Y., Ginjala V., Zhang L., Liu P.-Q., Oshimura M., Feinberg A.P., Wolffe A.P., Ohlsson R., and Gregory P.D. Targeted regulation of imprinted genes by synthetic zinc-finger transcription factors. Gene Ther. 10 (2003) 513-522
33. Yokoi K., Zhang H.S., Kachi S., Balaggan K.S., Yu Q., Guschin D., Kunis M., Surosky R., Africa L.M., Bainbridge J.W., Spratt S.K., Gregory P.D., Ali R.R., and Campochiaro P.A. Gene transfer of an engineered zinc finger protein enhances the anti-angiogenic defense system. Mol. Ther. 15 (2007) 1917-1923
34. Dreier B., Beerli R.R., Segal D.J., Flippin J.D., and Barbas III C.F. Development of zinc finger domains for recognition of the 5′-ANN-3′ family of DNA sequences and their use in the construction of artificial transcription factors. J. Biol. Chem. 276 (2001) 29466-29478
35. Dreier B., Fuller R.P., Segal D.J., Lund C.V., Blancafort P., Huber A., Koksch B., and Barbas III C.F. Development of zinc finger domains for recognition of the 5′-CNN-3′ family DNA sequences and their use in the construction of artificial transcription factors. J. Biol. Chem. 280 (2005) 35588-35597
36. Bae K.-H., Kwon Y.D., Shin H.-C., Hwang M.-S., Ryu E.-H., Park K.-S., Yang H.-Y., Lee D., Lee Y., Park J., Kwon H.S., Kim H.-W., Yeh B.-I., Lee H.-W., Sohn S.H., Yoon J., Soel W., and Kim J.-S. Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat. Biotechnol. 21 (2003) 275-280
37. Mandell J.G., and Barbas III C.F. Zinc finger tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res. 34 (2006) W516-W523
38. Choo Y., and Klug A. Selection of DNA-binding sites for zinc fingers using rationally randomized DNA reveals coded interactions. Proc. Natl. Acad. Sci. USA 91 (1994) 11168-11172
39. Wolfe S.A., Greisman H.A., Ramm E.I., and Pabo C.O. Analysis of zinc fingers optimized via phage display: evaluating the utility of a recognition code. J. Mol. Biol. 285 (1999) 1917-1934
40. Tachikawa K., Schroder O., Frey G., Briggs S.P., and Sera T. Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins. Proc. Natl. Acad. Sci. USA 101 (2004) 15225-15230
41. Sera T. Inhibition of virus DNA replication by artificial zinc finger proteins. J. Virol. 79 (2005) 2614-2619
42. Mino T., Hatono T., Matsumoto N., Mori T., Mineta Y., Aoyama Y., and Sera T. Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins. J. Virol. 80 (2006) 5405-5412
43. Mino T., Mori T., Aoyama Y., and Sera T. Cell-permeable artificial zinc-finger proteins as potent antiviral drugs for human papillomaviruses. Arch. Virol. 153 (2008) 1291-1298
44. Pearson H. Protein engineering: the fate of fingers. Nature 455 (2008) 160-164
45. Yang W.-P., Wu H., and Barbas III C.F. Surface plasmon resonance based kinetic studies of zinc finger-DNA interactions. J. Immunol. Methods 183 (1995) 175-182
46. Corbi N., Perez M., Maione R., and Passananti C. Synthesis of a new finger peptide; comparison of its "code" deduced and "CASTing" derived binding sites. FEBS Lett. 417 (1997) 71-74
47. Bulyk M.L., Huang X., Choo Y., and Church G.M. Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc. Natl. Acad. Sci. USA 99 (2001) 7158-7163
48. Meng X., Brodsky M.H., and Wolfe S.A. A bacterial one-hybrid system for determining the DNA-binding specificity of transcription factors. Nat. Biotechnol. 23 (2005) 988-994
49. Kalderon D., Roberts B.L., Richardson W.D., and Smith A.E. A short amino acid sequence able to specify nuclear location. Cell 39 (1984) 499-509
50. Triezenberg S.J., Kingsbury R.C., and McKnight S.L. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2 (1988) 718-729
51. Margolin J.F., Friedman J.R., Meyer W.K.-H., Vissing H., Thiesen H.-J., and Rauscher III F.J. Krüppel-associated boxes are potent transcriptional repression domains. Proc. Natl. Acad. Sci. USA 91 (1994) 4509-4513
52. Beerli R.B., Schopfe U., Dreier B., and Barbas III C.F. Chemically regulated zinc finger transcription factors. J. Biol. Chem. 275 (2000) 32617-32627
53. Xu L., Zerby D., Huang Y., Ji H., Nyanguile O.F., de los Angeles J.E., and Kadan M.J. A versatile framework for the design of ligand-dependent, transgene-specific transcription factors. Mol. Ther. 3 (2001) 262-273
54. Snowden A.W., Zhang L., Urnov F., Dent C., Jouvenot Y., Zhong X., Rebar E.J., Jamieson A.C., Zhang H.S., Tan S., Case C.C., Pabo C.O., Wolffe A.P., and Gregory P.D. Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors. Cancer Res. 63 (2003) 8968-8976
55. Dent C.L., Lau G., Drake E.A., Yoon A., Case C.C., and Gregory P.D. Regulation of endogenous gene expression using small molecule-controlled engineered zinc-finger protein transcription factors. Gene Ther. 15 (2007) 1362-1369
56. Magnenat L., Schwimmer L.J., and Barbas III C.F. Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches. Gene Ther. 15 (2008) 1223-1232
57. Pollock R., Issner R., Zoller K., Natesan S., Rivera V.M., and Clackson T. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc. Natl. Acad. Sci. USA 97 (2000) 13221-13226
58. Pollock R., Giel M., Linher K., and Clackson T. Regulation of endogenous gene expression with a small molecule dimerizer. Nat. Biotechnol. 20 (2002) 729-733
59. Zorko M., and Langel U. Cell-penetrating peptides: mechanisms and kinetics of cargo delivery. Adv. Drug Deliv. Rev. 57 (2005) 529-545
60. Ihara H., Mie M., Funabashi H., Takahashi F., Sawasaki T., Endo Y., and Kobatake E. In vitro selection of zinc finger DNA-binding proteins through ribosome display. Biochem. Biophys. Res. Commun. 345 (2006) 1149-1154
61. Bae K.-H., and Kim J.-S. One-step selection of artificial transcription factors using an in vivo screening system. Mol. Cells 21 (2006) 376-380
62. Joung J.K., Ramm E.I., and Pabo C.O. A bacterial two-hybrid selection system for studying protein-DNA and protein-protein interactions. Proc. Natl. Acad. Sci. USA 97 (2000) 7382-7387
63. Hurt J.A., Thibodeau S.A., Hirsh A.S., Pabo C.O., and Joung J.K. Highly specific zinc finger proteins obtained by directed domain shuffling and cell-based selection. Proc. Natl. Acad. Sci. USA 100 (2003) 12271-12276
64. Durai S., Bosley A., Abulencia A.B., Chandrasegaran S., and Ostermeier M. A bacterial one-hybrid selection system for interrogating zinc finger-DNA interactions. Comb. Chem. High Throughput Screen. 9 (2006) 301-311
65. Sepp A., and Choo Y. Cell-free selection of zinc finger DNA-binding proteins using in vitro compartmentalization. J. Mol. Biol. 354 (2005) 212-219
66. Choo Y., Sanchez-Garcia I., and Klug A. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 372 (1994) 642-645
67. Liu Q., Segal D.J., Ghiara J.B., and Barbas III C.F. Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc. Natl. Acad. Sci. USA 94 (1997) 5525-5530
68. Beerli R.R., Segal D.J., Dreier B., and Barbas III CF. Toward controlling gene expression at will: Specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc. Natl. Acad. Sci. USA 95 (1998) 14628-14633
69. Beerli R.R., Dreier B., and Barbas III C.F. Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Natl. Acad. Sci. USA 97 (2000) 1495-1500
70. Bartsevich V.V., and Juliano R.L. Regulation of the MDR1gene by transcriptional repressors selected using peptide combinatorial libraries. Mol. Pharmacol. 58 (2000) 1-10
71. Lund G.V., Popkov M., Magnenat L., and Barbas III C.F. Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology. Mol. Cell. Biol. 25 (2005) 9082-9091
72. Rebar E.J., Huang Y., Hickey R., Nath A.K., Meoli D., Nath S., Chen B., Xu L., Liang Y., Jamieson A.C., Zhang L., Spratt S.K., Case C.C., Wolffe A., and Giordano F.J. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat. Med. 8 (2002) 1427-1432
73. Yu J., Lei L., Liang Y., Hinh L., Hickey R.P., Huang Y., Liu D., Yeh J.L., Rebar E., Case C., Spratt K., Sessa W.C., and Giordano F.J. An engineered VEGF-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice. FASEB J. 20 (2006) 479-481
74. Price S.A., Dent C., Duran-Jimenez B., Ling Y., Zhang L., Rebar E.J., Case C.C., Gregory P.D., Martin T.J., Spratt S.K., and Tomlinson D.R. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes 55 (2006) 1847-1854
75. Dai Q., Huang J., Klitzman B., Dong C., Goldschmidt-Clermont P.J., March K.L., Rokovich J., Johnstone B., Rebar E.J., Spratt S.K., Case C.C., Kontos C.D., and Annex B.H. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia. Circulation 110 (2004) 2467-2475
76. Hirastu K., Matsui K., Koyama T., and Ohme-Takagi M. Dominant repression of target genes by chimeric repressors that include the EAR motif, a repression domain, in Arabidopsis. Plant J. 34 (2003) 733-739
77. Vivès E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
78. Ho A., Schwarze S.R., Mermelstein S.J., Waksman G., and Dowdy S.F. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61 (2001) 474-477
79. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 97 (2000) 13003-13008
80. Kang Y.-A., Shin H.-C., Yoo J.Y., Kim J.-H., Kim J.-S., and Yun C.-O. Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus. Mol. Ther. 16 (2008) 1033-1040
81. Kwon H.-S., Shin H.-C., and Kim J.-S. Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels. Nucleic Acids Res. 33 (2005) e74
82. Kim J., Kim J.-H., Choi K.-J., Kim P.-W., and Yun C.-O. E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects. Hum. Gene Ther. 18 (2007) 773-786
83. Ren D., Collingwood T.N., Rebar E.J., Wolffe A.P., and Camp H.S. PPARg knockdown by engineered transcription factors: exogenous PPARg2but not PPARg1 reactivates adipogenesis. Genes Dev. 2 (1988) 718-729
84. Falke D., Fisher M., Ye D., and Juliano R.L. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene. Nucleic Acids Res. 31 (2003) e10
85. Bartsevich V.V., Miller J.C., Case C.C., and Pabo C.O. Engineered zinc finger proteins for controlling stem cell fate. Stem Cells 21 (2003) 532-637
86. Tan S., Guschin D., Davalos A., Lee Y.-L., Snowden A.W., Jouvenot Y., Zhang H.S., Howes K., McNamara A.R., lai A., Ullman C., Reynolds L., Moore M., Isalan M., Berg L.-P., Campos B., Qi H., Spratt S.K., Case C.C., Pabo C.O., Campisis J., and Gregory P.D. Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc. Natl. Acad. Sci. USA 100 (2003) 11997-12002
87. Liu P.-Q., Morton M.F., Reik A., De La Rosa R., Mendel M.C., Li X.-Y., Case C.C., Pabo C.O., Moreno V., Kempf A., Pyati J., and Shankley N.P. Cell lines for drug discovery: elevating target-protein levels using engineered transcription factors. J. Biomol. Screen. 9 (2004) 44-51
88. Liu P.-Q., Tan S., Mendel M.C., Murrills R.J., Bhat B.M., Schlag B., Samuel R., Matteo J.J., deLa Rosa R., Howes K., Reik A., Case C.C., Bex F.J., Young K., and Gregory P.D. Isogenic human cell lines for drug discovery: regulation of target gene expression by engineered zinc-finger protein transcription factors. J. Biomol. Screen. 10 (2005) 304-313
89. Gräslund T., Li X., Magnenat L., Popkov M., and Barbas III C.F. Exploring strategies for the design of artificial transcription factors. J. Biol. Chem. 280 (2005) 3707-3714
90. Beltran A., Parikh S., Liu Y., Johnson G.L., Futscher B.W., and Blancafort P. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors. Oncogene 26 (2007) 2791-2798
91. Onori A., Desantis A., Buontempo S., Grazia M., Di Certo, Fanciulli M., Salvatori L., Passananti C., and Corbi N. The artificial 4-zinc-finger protein Bagly binds human utrophin promoter A at the endogenous chromosomal site and activates transcription. Biochem. Cell. Biol. 85 (2007) 358-365
92. Mattei E., Corbi N., Di Certo M.G., Strimpakos G., Severini C., Onori A., Desantis A., Libri V., Buontempo S., Floridi A., Fanciulli M., Baban D., Davies K.E., and Passananti C. Utrophin up-regulation by an artificial transcription factor in transgenic mice. PLoS One 2 (2007) e774
93. Beltran A.S., Sun X., Lizardi P.M., and Blancafort P. Reprograming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. Mol. Cancer Ther. 7 (2008) 1080-1090
94. Blancafort P., Magnenat L., and Barbas III C.F. Scanning the human genome with combinatorial transcription factor libraries. Nat. Biotechnol. 21 (2003) 269-274
95. Magnenat L., Blancafort P., and Barbas III C.F. In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulation. J. Mol. Biol. 341 (2004) 635-649
96. Lee D., Kim Y.H., Kim J.-S., and Seol W. Induction and characterization of taxol-resistance phenotypes with a transiently expressed artificial transcriptional activator library. Nucleic Acids Res. 32 (2004) e116
97. Park K.-S., Lee D., Lee H., Lee Y., Jang Y.-S., Kim Y.H., Yang H.-Y., Lee S.-I., Soel W., and Kim J.-S. Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors. Nat. Biotechnol. 21 (2003) 1208-1214
98. Blancafort P., Chen E.I., Gonzalez B., Bergquist S., Zijlstra A., Guthy D., Brachat A., Brakenhoff R.H., Quigley J.P., Erdmann D., and Barbas III C.F. Genetic regrogramming of tumor cells by zinc finger transcription factors. Proc. Natl. Acad. Sci. U.S.A. 102 (2003) 11716-11721
99. Blancafort P., Tschan M.P., Bergquist S., Guthy D., Brachat A., Sheeter D.A., Torbett B.E., Erdmann D., and Barbas III C.F. Modulation of drug resistance by artificial transcription factors. Mol. Cancer Ther. 7 (2008) 688-697
100. Frankel A.D., and Pabo C.O. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
101. Gupta B., Levchenko T.S., and Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 57 (2005) 637-651
102. Richard J.P., Melikov K., Vivès E., Ramos C., Verbeure B., Gait M.J., Chernmordik L.V., and Lebleu B. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. J. Biol. Chem. 278 (2003) 585-590
103. Deshayes S., Morris M.C., Divita G., and Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Adv. Drug Deliv. Rev. 57 (2005) 637-651
104. Yun C.-O., Shin H.-C., Kim T.-D., Yoon W.-H., Kang Y.-A., Kwon H.-S., Kim S.K., and Kim J.-S. Transduction of artificial transcription regulatory proteins into human cells. Nucleic Acids Res. 36 (2008) e103
105. Andrei G., Snoeck R., Piette J., Delvenne P., and De Clercq E. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncol. Res. 10 (1998) 523-531
106. Reynolds L., Ullman C., Moore M., Isalan M., West M.J., Clapham P., Klug A., and Choo Y. Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1615-1620
107. Segal D.J., Gonçalves J., Eberhardy S., Swan C.H., Torbett B.E., Li X., and Barbas III C.F. Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor. J. Biol. Chem. 279 (2004) 14509-14519
108. Kim Y.-S., Kim J.-M., Jung D.-L., Kang J.-E., Lee S., Kim J.S., Seol W., Shin H.-C., Kwon H.S., Lint C.V., Hernandez N., and Hur M.-W. Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1. J. Biol. Chem. 280 (2005) 21545-21552
109. Eberhardy S.R., Goncalves J., Coelho S., Segal D.J., Berkhout B., and Barbas III C.F. Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site. J. Virol. 80 (2006) 2873-2883
110. Papworth M., Moore M., Isalan M., Minczuk M., Choo Y., and Klug A. Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1621-1626
111. Zimmerman K.A., Fischer K.P., Joyce M.A., and Tyrrell D.L.J. Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture. J. Virol. 82 (2008) 8013-8021
112. Ruben S.M., Dillon P.J., Schreck R., Henkel T., Chen C.-H., Maher M., Baeuerle P.A., and Rosen C.A. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kB. Science 251 (1991) 1490-1493
113. Ayer D.E., Laherty C.D., Lawrence Q.A., Armstrong A.P., and Eisenman R.N. Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16 (1992) 5772-5781
114. Sgouras D.N., Beal Jr. G.J., Fisher R.J., Blair D.G., and Mavrothalassitis G.J. ERF: an ETS domain protein with strong transcriptional represssor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J. 14 (1995) 4781-4793